Lancet Rheumatology

Scope & Guideline

Advancing knowledge in rheumatology and immunology.

Introduction

Welcome to your portal for understanding Lancet Rheumatology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2665-9913
PublisherELSEVIER
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationLANCET RHEUMATOL / Lancet Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Lancet Rheumatology journal focuses on advancing the understanding and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aim is to provide a platform for innovative research that can improve patient outcomes and guide clinical practice.
  1. Rheumatic Disease Research:
    The journal emphasizes research on various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome, exploring their pathophysiology, diagnosis, and management.
  2. Clinical Trials and Interventions:
    A significant focus is on clinical trials evaluating new therapies, treatment strategies, and interventions aimed at improving patient care and outcomes in rheumatology.
  3. Patient-Centered Approaches:
    The journal promotes research that incorporates patient perspectives, emphasizing the importance of patient-reported outcomes and engagement in treatment decisions.
  4. Emerging Therapies and Precision Medicine:
    A core area of interest involves exploring novel therapeutics, including biologics and targeted therapies, and their application in personalized medicine for rheumatic diseases.
  5. Public Health and Epidemiology:
    Research addressing the epidemiology of rheumatic diseases, health disparities, and the impact of socioeconomic factors on disease management is also a critical focus.
  6. COVID-19 and Autoimmunity:
    Given the recent pandemic, the journal has increasingly published studies on the intersection of COVID-19 and rheumatic diseases, including vaccine responses and management strategies.
The Lancet Rheumatology has been at the forefront of several emerging themes in rheumatology research, reflecting the evolving landscape of the field.
  1. Digital Health and Telemedicine:
    Recent publications highlight the growing integration of digital health technologies and telemedicine in managing rheumatic diseases, especially in the context of the COVID-19 pandemic.
  2. Vaccine Research in Autoimmune Diseases:
    There is a marked increase in research focused on vaccine responses among patients with autoimmune conditions, particularly regarding COVID-19 vaccinations and their implications for treatment.
  3. Health Equity and Social Determinants:
    Emerging themes include a focus on health equity, social determinants of health, and their impact on the management of rheumatic diseases, addressing disparities in care.
  4. Patient Engagement and Self-Management:
    There is a rising trend in research exploring patient engagement strategies and self-management approaches, emphasizing the importance of involving patients in their care.
  5. Precision Medicine and Biomarkers:
    The journal increasingly features studies on precision medicine, with a focus on identifying biomarkers that can guide treatment decisions and improve patient outcomes.
  6. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on rheumatology care continues to be a significant area of research, with studies evaluating the effects on disease management and patient safety.

Declining or Waning

While the journal has seen growth in certain areas, some themes have become less prominent over recent years, indicating a potential shift in research focus.
  1. Traditional Therapies:
    There has been a noticeable decline in papers focused on traditional treatments for rheumatic diseases, such as corticosteroids and non-steroidal anti-inflammatory drugs, as the field shifts towards biologics and targeted therapies.
  2. Basic Science Research:
    The journal has published fewer studies centered exclusively on basic science, such as bench research, as the emphasis moves towards translational and clinical research that directly impacts patient care.
  3. Longitudinal Studies in Established Cohorts:
    Research utilizing long-term follow-up of established cohorts has decreased, potentially as the emphasis shifts towards more immediate clinical trials and interventions.
  4. Single-Center Studies:
    There appears to be a waning interest in single-center studies, with a preference for multicenter collaborations that can provide broader insights and more robust data.

Similar Journals

Arthritis & Rheumatology

Elevating Standards in Rheumatology Science
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Lupus Science & Medicine

Fostering collaboration for a lupus-free future.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Egyptian Rheumatologist

Advancing rheumatology through open dialogue.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

RMD Open

Pioneering open-access research in rheumatic diseases.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

Modern Rheumatology

Transforming Research into Clinical Excellence
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Rheumatology and Therapy

Fostering breakthroughs in immunology and rheumatology.
Publisher: SPRINGERISSN: 2198-6576Frequency: 4 issues/year

Rheumatology and Therapy, published by Springer, stands as a prominent open-access journal within the fields of Immunology and Allergy and Rheumatology. Since its inception in 2014, the journal has made significant contributions to advancing the understanding, diagnosis, and treatment of rheumatic diseases, garnering a solid reputation with an impact factor that reflects its rigorous peer-review process and scholarly influence. Currently ranked in the Q2 quartile for both its categories according to 2023 metrics, it occupies a significant position among its peers, standing at Rank #21 out of 73 in Medicine Rheumatology and Rank #101 out of 233 for Medicine Immunology and Allergy. The journal's scope encompasses cutting-edge research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and patient care, making it an invaluable resource for researchers, clinicians, and students alike. With its commitment to open access, Rheumatology and Therapy ensures that high-quality research is available to a global audience, fostering collaboration and innovation in rheumatology and immunology. To learn more, visit their official site and explore the wealth of knowledge available.

Nature Reviews Gastroenterology & Hepatology

Unveiling the Future of Digestive Health Research
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

Current Rheumatology Reports

Connecting clinicians and researchers for better outcomes.
Publisher: SPRINGERISSN: 1523-3774Frequency: 12 issues/year

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders

Illuminating the path to improved musculoskeletal treatments.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5441Frequency: 1 issue/year

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.

Revista Cubana de Reumatologia

Empowering global collaboration in rheumatology.
Publisher: SOC CUBANA REUMATOLOGIAISSN: 1606-5581Frequency: 2 issues/year

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.